Use access key #2 to skip to page content.

JimVanMeerten (56.88)

Novartis AG



May 12, 2014 – Comments (1) | RELATED TICKERS: NVS

The Chart of the Day is Novartis AG (NVS).  I fount the stock by sorting the 52 Week New High List for new high frequency in the last month, then used the Flipchart feature to review the charts.  Since the Trend Spotter signaled another buy on 3/34 the stock gained another 4.23%

Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work. (Press Release)

The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the web site when you read this report.

Barchart technical indicators:

96% Barchart technical buy signals

Trend Spotter buy signal

Above its 20, 50 and 100 day moving averages

16 new highs and up 7.19% in the last month

Relative Strength Index 68.79%

Barchart computes a technical support level at 88.18

Recently traded at 88.61 with a 50 day moving average of 84.08

Fundamental factors:

Market Cap $214.97 billion

P/E 17.37

Dividend yield 2.04%

Revenue expected to grow 1.80% this year and an other 1.50% next year

Earnings estimated to increase 5.40% this year, an additional 4.70% next year and continue to increase at an annual rate of 5.40% for the next 5 years

Wall Street analysts issued 2 strong buy and 4 holds on the stock

If you have to have one big cap pharma, this might be it.  Use the 50 day moving average to gauge sings of weakness and the 100 day moving average to exit.

1 Comments – Post Your Own

#1) On May 12, 2014 at 11:20 PM, ikkyu2 (98.18) wrote:

I like both Biogen (BIIB) and Teva (TEVA) better.

Report this comment

Featured Broker Partners